Beijing Leadman Biochemistry Co.,Ltd.

300289

CNE100001C22

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 15/07/2024 BST			5-day change	1st Jan Change
3.72 ^CNY	-1.33%		-1.06%	-39.51%

05-13	Beijing Leadman Biochemistry Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 17 May 2024	CI
04-30	Beijing Leadman Biochemistry Co.,Ltd Approves the Cash Dividend for the Year 2023	CI

Beijing Leadman Biochemistry Co.,Ltd Approves the Cash Dividend for the Year 2023

April 29, 2024

Beijing Leadman Biochemistry Co.,Ltd. at its Annual General Meeting of 2023 held on 29 April 2024, approved the Cash dividend/10 shares (tax included) of CNY 0.10000000 for the year 2023.

Latest news about Beijing Leadman Biochemistry Co.,Ltd.

Beijing Leadman Biochemistry Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 17 May 2024	05-13	CI
Beijing Leadman Biochemistry Co.,Ltd Approves the Cash Dividend for the Year 2023	04-29	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Beijing Leadman Biochemistry Co.,Ltd. Proposes Final Cash Dividend for 2023	03-27	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Leadman Biochemistry Unit Obtains Shanghai Clearance for Fatty Acid Kit	03-15	MT
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/10/23	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	11/08/23	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20/04/23	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/03/23	CI
Shenzhen Uni-medica Technology Co., Ltd. announced that it has received CNY 20 million in funding from Beijing Leadman Biochemistry Co.,Ltd.	18/12/22	CI
Shenzhen Uni-medica Technology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Beijing Leadman Biochemistry Co.,Ltd.	07/11/22	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21/10/22	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18/08/22	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22/04/22	CI
Beijing Leadman Biochemistry Co.,Ltd. Approves Cash Dividend for the Year 2021	13/04/22	CI
Beijing Leadman Biochemistry Co.,Ltd. Proposes Final Dividend for the Year 2021	21/03/22	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	18/03/22	CI
Beijing Leadman Biochemistry Co.,Ltd. Approves Board Appointments	01/12/21	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI
Beijing Yongtai Enter into the Lease Agreement with Beijing Leadman Biochemistry Co.,Ltd	11/10/21	CI
Beijing Leadman Biochemistry : Raises $85 Million From Private Share Sale; Shares Rise Nearly 3%	03/09/21	MT
Beijing Leadman Biochemistry Co.,Ltd. announced that it has received CNY 556.6 million in funding from Guangzhou GET Technologies Development Co., Ltd	17/08/21	CI
Beijing Leadman Biochemistry Co.,Ltd. Announces Earnings Results for the Half Year Ended June 30, 2021	12/08/21	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First quarter Ended March 31, 2021	27/04/21	CI

Chart Beijing Leadman Biochemistry Co.,Ltd.

Duration

Period

Chart Beijing Leadman Biochemistry Co.,Ltd.

More charts

Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

16/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD.	-39.51%	283M
BIOMÉRIEUX	-6.66%	12.28B
LANTHEUS HOLDINGS, INC.	+90.81%	8.54B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-22.14%	6.58B
DIASORIN S.P.A.	+8.86%	5.77B
AUTOBIO DIAGNOSTICS CO., LTD.	-23.82%	3.48B
ANDON HEALTH CO., LTD.	+5.12%	2.54B
MYRIAD GENETICS, INC.	+43.10%	2.41B
VITROLIFE AB	-7.24%	2.3B
10X GENOMICS, INC.	-64.26%	2.07B

Diagnostic & Testing Substances